Mumbai, July 28 -- The board of Torrent Pharmaceuticals has approved the appointment of Shanti Ekambaram (DIN: 00004889) as an Additional Independent

Director of the Company for a term of 3 consecutive years effective from 30 July 2026, subject to approval of the shareholders of the Company.

Published by HT Digital Content Services with permission from Capital Market....